RU93051787A - ELIMINATING ISOMER 6- (5-CHLOR-2-PYRIDIL) - (4-METHYL-1-PIPERAZINYL) -5-CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRRO- [3,4-V] Pyrazyl , METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION BASED ON IT AND METHOD OF IMPROVING SLEEP - Google Patents

ELIMINATING ISOMER 6- (5-CHLOR-2-PYRIDIL) - (4-METHYL-1-PIPERAZINYL) -5-CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRRO- [3,4-V] Pyrazyl , METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION BASED ON IT AND METHOD OF IMPROVING SLEEP

Info

Publication number
RU93051787A
RU93051787A RU93051787/04A RU93051787A RU93051787A RU 93051787 A RU93051787 A RU 93051787A RU 93051787/04 A RU93051787/04 A RU 93051787/04A RU 93051787 A RU93051787 A RU 93051787A RU 93051787 A RU93051787 A RU 93051787A
Authority
RU
Russia
Prior art keywords
carbonyloxy
piperazinyl
isomer
dihydro
oxo
Prior art date
Application number
RU93051787/04A
Other languages
Russian (ru)
Other versions
RU2110519C1 (en
Inventor
Котрель Клод
Руссель Жерар
Original Assignee
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9100490A external-priority patent/FR2671800B1/en
Application filed by Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А.
Publication of RU93051787A publication Critical patent/RU93051787A/en
Application granted granted Critical
Publication of RU2110519C1 publication Critical patent/RU2110519C1/en

Links

Claims (1)

Изобретение относится к правовращаемому изомеру 6-(5-хлор-2-пиридил)-(4-метил-1-пиперазинил) -5-карбонилокси-7-оксо-6,7 -дигидро-5Н-пирроло- [3,4-] пиразина, к способу его получения и к использованию его в качестве успокаивающего и снотворного агента в фармацевтическом составе.SUBSTANCE: invention relates to a right rotatable isomer of 6- (5-chloro-2-pyridyl) - (4-methyl-1-piperazinyl) -5-carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo- [3,4- ] pyrazine, to the method of its production and to use it as a sedative and hypnotic agent in the pharmaceutical composition.
RU93051787A 1991-01-17 1992-01-16 Dextrorotatory isomer of 6-(5-chloro-2-pyridyl)-(4-methyl-1- -piperazinyl)-5-carbonyloxy-7-oxo-6,7-dihydro-5h-pyrrolo- -[3,4-b]-pyrazine and its pharmaceutically acceptable acid-additive salt, method of their synthesis and pharmaceutical composition based on thereof RU2110519C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9100490A FR2671800B1 (en) 1991-01-17 1991-01-17 OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
FR9100490 1991-01-17

Publications (2)

Publication Number Publication Date
RU93051787A true RU93051787A (en) 1996-02-27
RU2110519C1 RU2110519C1 (en) 1998-05-10

Family

ID=9408772

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93051787A RU2110519C1 (en) 1991-01-17 1992-01-16 Dextrorotatory isomer of 6-(5-chloro-2-pyridyl)-(4-methyl-1- -piperazinyl)-5-carbonyloxy-7-oxo-6,7-dihydro-5h-pyrrolo- -[3,4-b]-pyrazine and its pharmaceutically acceptable acid-additive salt, method of their synthesis and pharmaceutical composition based on thereof

Country Status (29)

Country Link
US (5) US6319926B1 (en)
EP (2) EP0495717A1 (en)
JP (1) JPH06504548A (en)
AR (1) AR248024A1 (en)
AT (1) ATE121089T1 (en)
AU (2) AU671797B2 (en)
CA (1) CA2099782C (en)
CZ (1) CZ281011B6 (en)
DE (1) DE69202060T2 (en)
DK (1) DK0609210T3 (en)
ES (1) ES2071486T3 (en)
FI (1) FI100331B (en)
FR (1) FR2671800B1 (en)
HU (1) HU218928B (en)
IE (1) IE66110B1 (en)
IL (1) IL100677A (en)
MA (1) MA22392A1 (en)
MX (1) MX9200180A (en)
NO (1) NO179911C (en)
NZ (1) NZ241313A (en)
OA (1) OA09807A (en)
PH (1) PH30982A (en)
PL (1) PL166976B1 (en)
RU (1) RU2110519C1 (en)
SK (1) SK279060B6 (en)
TN (1) TNSN92004A1 (en)
WO (1) WO1992012980A1 (en)
YU (1) YU48878B (en)
ZA (1) ZA92302B (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671800B1 (en) 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
US5786357A (en) 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
ES2101653B1 (en) * 1995-07-10 1998-04-01 Asturpharma S A (+) - 6- (5-CHLOROPIRID-2-IL) -7-OXO-VINYLOXICARBONYLLOXI-5,6-DIHYDROPYROL (3,4B) PIRAZINE AND ITS USE FOR A PREPARATION PROCEDURE FOR (+) - 6- (5 -CHLOROPIRID-2-IL) -5- (4-METHYLPIPERAZIN-1-IL) -CARBONYLLOXI-7-OXO-5,6-DIHYDROPYROL (3,4B) PYRAZINE.
US6339086B1 (en) * 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
TW200734459A (en) 1999-10-04 2007-09-16 Ajinomoto Kk Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
DK1691811T3 (en) 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc COMBINATION OF A SEDATIVE AND NEUROTRANSMITTER MODULATOR AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATMENT OF DEPRESSION
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
JP2007517040A (en) * 2003-12-24 2007-06-28 セプレイコー インコーポレイテッド Melatonin combination therapy to improve sleep quality
DK1742624T3 (en) * 2004-02-18 2010-03-08 Sepracor Inc Dopamine agonist combination therapy with sedatives to improve sleep quality
JP4970244B2 (en) 2004-04-05 2012-07-04 サノビオン ファーマシューティカルズ インク Treatment with eszopiclone
WO2006136866A1 (en) * 2005-06-21 2006-12-28 Generics [Uk] Limited Process for enantiomeric separation of zopiclone
EP1904066B1 (en) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
CN101257898A (en) * 2005-07-06 2008-09-03 塞普拉科公司 Combinations of eszopiclone and O-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
US7476737B2 (en) * 2005-09-05 2009-01-13 Dr. Reddy's Laboratories Limited Eszopiclone process
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1984368A2 (en) * 2006-01-17 2008-10-29 Glenmark Pharmaceuticals Limited Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b]pyrazine derivative
AR059296A1 (en) * 2006-02-03 2008-03-26 Synthon Bv S-ZOPICLONE L-TARTRATE COMPOSITE AND PROCESS TO RESOLVE ZOPICLONA ENANTIOMERS.
US20080027223A1 (en) * 2006-03-23 2008-01-31 Teva Pharmaceutical Industries Ltd. Polymorphs of eszopiclone malate
US20070270590A1 (en) * 2006-04-20 2007-11-22 Marioara Mendelovici Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
EP1904499A1 (en) * 2006-06-26 2008-04-02 Teva Pharmaceutical Industries Ltd Process for the preparation of zopiclone
US7786304B2 (en) * 2006-11-06 2010-08-31 Centaur Pharmaceutical Pvt. Ltd. Process for the preparation of eszopiclone
TW200846340A (en) * 2007-01-31 2008-12-01 Teva Pharma Methods for preparing eszopiclone
ATE515259T1 (en) * 2007-05-29 2011-07-15 Lek Pharmaceuticals PHARMACEUTICAL COMPOSITION CONTAINING ESZOPICLONE
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
WO2009002552A1 (en) * 2007-06-25 2008-12-31 Teva Pharmaceutical Industries Ltd. Racemization process of r-zopiclone
EP2020403A1 (en) 2007-08-02 2009-02-04 Esteve Quimica, S.A. Process for the resolution of zopiclone and intermediate compounds
US20090198058A1 (en) * 2007-08-06 2009-08-06 Dhananjay Govind Sathe Process for Preparation of Dextrorotatory Isomer of 6-(5- chloro-pyrid-2-yl)-5-[(4-methyl -1-piperazinyl) carbonyloxy] -7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b] pyrazine (Eszopiclone)
CA2747000C (en) * 2007-12-19 2013-09-03 Sunovion Pharmaceuticals Inc. Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
US8268832B2 (en) * 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
WO2009085988A1 (en) * 2007-12-19 2009-07-09 Sepracor Inc. Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine
US8198277B2 (en) 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8269005B2 (en) * 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8198278B2 (en) 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8212036B2 (en) 2007-12-19 2012-07-03 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
WO2009101634A2 (en) * 2008-02-13 2009-08-20 Lupin Limited A novel process for the preparation of eszopiclone
CA2719097A1 (en) 2008-03-12 2009-09-17 Emory University Use of gabaa receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness
US20090269409A1 (en) * 2008-04-24 2009-10-29 Mukesh Kumar Garg Pharmaceutical compositions comprising eszopiclone
CN101607961B (en) * 2008-06-18 2011-08-10 天津天士力集团有限公司 Eszopiclone crystal and composition thereof
AU2009312607A1 (en) 2008-11-07 2010-05-14 Cipla Limited Process for resolving zopiclone
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CA2750059C (en) 2009-01-30 2014-11-18 Sunovion Pharmaceuticals Inc. Coated tablets of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine and methods for measuring effectiveness of coating
WO2010116385A2 (en) 2009-04-08 2010-10-14 Rubicon Research Private Limited Pharmaceutical compositions for alleviating unpleasant taste
EP2345654A1 (en) 2010-01-05 2011-07-20 LEK Pharmaceuticals d.d. Eszopiclone particles and a process for their preparation
EP2345655A1 (en) 2010-01-05 2011-07-20 LEK Pharmaceuticals d.d. A process for racemisation of 6-(5-chloropyridin-2-yl)-7-(4-methyl-1-piperazinyl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
CN103193779B (en) * 2012-01-05 2016-04-20 成都弘达药业有限公司 A kind of preparation method of Lunesta
EP2934486A2 (en) * 2012-12-20 2015-10-28 Kashiv Pharma, LLC Orally disintegrating tablet formulation for enhanced bioavailability
US9636340B2 (en) 2013-11-12 2017-05-02 Ayyappan K. Rajasekaran Kinase inhibitors
JP2020007252A (en) * 2018-07-05 2020-01-16 アクティブファーマ株式会社 Method for producing eszopiclone dibenzoyl-D-tartrate, method for producing eszopiclone, and crystal of eszopiclone dibenzoyl-D-tartrate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04285A (en) * 1972-01-07 1979-12-31 Rhone Poulenc Sa New derivatives of pyrrolo (3,4-b) pyrazine and their preparation.
AR208414A1 (en) * 1974-11-07 1976-12-27 Rhone Poulenc Ind PROCEDURE TO OBTAIN NEW DERIVATIVES OF ((ACIL-4PIPERAZINIL-1) CARBONYLOXI-5 PYRROLINONE-2)
US4962124A (en) 1987-11-17 1990-10-09 Analgesic Associates Onset-hastened/enhanced antipyretic response
US4868214A (en) 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US5102890A (en) 1989-09-05 1992-04-07 Rhone-Poulenc Sante Pyrrole derivatives, their preparation and pharmaceutical compositions which contain them
FR2671800B1 (en) 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
AU3275993A (en) 1991-12-02 1993-06-28 Sepracor, Inc. Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone
US5786357A (en) * 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
US5331000A (en) 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US6436926B1 (en) * 1999-05-10 2002-08-20 Medpointe, Inc. Compositions and methods for treating superficial fungal infections
US7476737B2 (en) * 2005-09-05 2009-01-13 Dr. Reddy's Laboratories Limited Eszopiclone process
AR059296A1 (en) * 2006-02-03 2008-03-26 Synthon Bv S-ZOPICLONE L-TARTRATE COMPOSITE AND PROCESS TO RESOLVE ZOPICLONA ENANTIOMERS.

Similar Documents

Publication Publication Date Title
RU93051787A (en) ELIMINATING ISOMER 6- (5-CHLOR-2-PYRIDIL) - (4-METHYL-1-PIPERAZINYL) -5-CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRRO- [3,4-V] Pyrazyl , METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION BASED ON IT AND METHOD OF IMPROVING SLEEP
DE69202060T2 (en) OPTICALLY ACTIVE 5H-PYRROLO [3,4-b] PYRAZINE DERIVATIVE, ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT.
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
MX9202838A (en) IMIDAZO [1,5-A] QUINOXALINAS.
CA2322311A1 (en) Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
IL89796A (en) (1:, 2, 3:)-2, 3-bis- (hydroxymethyl)- 1-cylobutylpurine, triazolo (3,4-d) pyrimidine and pyrimidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
FR2607813B1 (en) ALKYLAMINO-8 IMIDAZO (1,2-A) PYRAZINES AND DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2786770B1 (en) NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EE9700020A (en) Heteroatom-containing cyclopentanepyridyloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
HUT61311A (en) Process for producing /1,2,4/triazolo/1,5-a//1,3,5/-traizine and pyrazolo/2,3-a//1,3,5/-triazine derivatives and pharmaceutical compositions comprising same as active ingredient
BG51046A3 (en) Method for the preparation of pyrido (1, 2- a) pyrazine derivatives
NO900613D0 (en) PROCEDURE FOR THE PREPARATION OF ACTIVATED CHITOSANES AND USE IN THE PREPARATION OF CHITOSANDER DERIVATIVES.
HUT45529A (en) Process for producing pyrazolo/3,4-d/pyrimidine derivatives and pharmaceutics comprising these compounds as active ingredient
ATE205846T1 (en) 2,7-SUBSTITUTED OCTAHYDROPYRROLO(1,2-A)PYRAZINE DERIVATIVES
FR2661919B1 (en) PROCESS FOR THE PREPARATION OF FURO (3,4-C) PYRIDINE DERIVATIVES IN NON-RACEMIC FORM.
NZ229346A (en) Oxadiazolyl-substituted imidazo(1,5-a)quinoxaline derivatives and pharmaceutical compositions
IL102536A0 (en) Imidazo(2,1-b)benzothiazole-3-acetamide derivatives,their preparation and their use in therapeutics
LV12188A (en) Use of tricyclic derivatives of 1,4-Dihydro-1,4-dioxo-1H-naphthalene for the acquisition of new compounds and their use in therapy
ZA892869B (en) 5-fluoromethyl-1,2,4-triazolo(1,5-a)-pyrimidine-2-sulfonamides,process for their preparation and composition for their use as herbicides
EE200200260A (en) Pyrazolo [1,5-d] [1,2,4] triazine derivative, its preparation and its use in the preparation of a medicament for the enhancement of cognition, and a pharmaceutical composition containing it
NO902934L (en) PROCEDURE FOR THE PREPARATION OF 4H-INDOLO (1,2-D) (1,2,4) -TRIAZOLO (4,3-A) (1,4) BENZODIAZEPINES, AND USE AS MEDICINES.
IT8067738A0 (en) PROCEDURE FOR THE PREPARATION OF PYRROLE TETRAHYD [1,2-A] 3-SUBSTITUTED PYRIMIDINES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PYRROLE TETRAHYD [1,2-A] 3-SUBSTITUTED PYRIMIDINES
IL95312A0 (en) Substituted pyrazine,its preparation and pharmaceutical compositions containing it
ZA957464B (en) Pyrimido[5,4-d]pyrimidines medicaments comprising these compounds their use and processes for the preparation
FR2659332B1 (en) NOVEL PYRROLO [1,2-A] THIENO [3,2-F] DIAZEPINES [1,4], THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.